Telemedicine for diabetes care: An Indian perspective - feasibility and efficacy

Diabetes is a chronic and costly disease. In India, the usual practice among patients is to visit the doctor once in every 2–3 months to get advice on changes in the dosages of medications. The Diabetes Tele Management System (DTMS®) is a telemedicine based follow-up program originally introduced at...

Full description

Bibliographic Details
Main Authors:	Kesavadev, Jothydev, Saboo, Banshi, Shankar, Arun, Krishnan, Gopika, Jothydev, Sunitha
Format:	Online
Language:	English
Published:	Medknow Publications & Media Pvt Ltd 2015
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4673803/

id	pubmed-4673803
recordtype	oai_dc
spelling	pubmed-46738032015-12-21 Telemedicine for diabetes care: An Indian perspective - feasibility and efficacy Kesavadev, Jothydev Saboo, Banshi Shankar, Arun Krishnan, Gopika Jothydev, Sunitha Review Article Diabetes is a chronic and costly disease. In India, the usual practice among patients is to visit the doctor once in every 2–3 months to get advice on changes in the dosages of medications. The Diabetes Tele Management System (DTMS®) is a telemedicine based follow-up program originally introduced at Jothydev's Diabetes Research Centre at Trivandrum South India in 1998. It is a chronic disease management system which enables patient to interact lively with a professionally trained multidisciplinary team comprising of diabetes educators, nurses, dieticians, pharmacists, psychologists, physicians, etc., in modifying the dosages of medications, diet, and physical activity either through telephone/email/secure website. The uniquely designed software and the trained multidisciplinary team overcomes the globally recognized major barriers to diabetes management namely fear of hypoglycemia, polypharmacy, discontinuation of stains, and antihypertensives or wrong injection techniques. DTMS is designed to provide individualized therapy advices on glycosylated hemoglobin, blood pressure, and low density lipoprotein customized to multiple patient characteristics which help attain goals of therapy. The system has been tested on various platforms over a decade and was shown to be a patient friendly approach with successful outcomes due to a live “round-the-clock” interactive communication in contrast to text or recorded messages. The major challenge to the widespread use of DTMS® is seeking a source of funding this unique telemedicine program. Medknow Publications & Media Pvt Ltd 2015 /pmc/articles/PMC4673803/ /pubmed/26693425 http://dx.doi.org/10.4103/2230-8210.167560 Text en Copyright: © Indian Journal of Endocrinology and Metabolism http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution NonCommercial ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non commercially, as long as the author is credited and the new creations are licensed under the identical terms.
repository_type	Open Access Journal
institution_category	Foreign Institution
institution	US National Center for Biotechnology Information
building	NCBI PubMed
collection	Online Access
language	English
format	Online
author	Kesavadev, Jothydev Saboo, Banshi Shankar, Arun Krishnan, Gopika Jothydev, Sunitha
spellingShingle	Kesavadev, Jothydev Saboo, Banshi Shankar, Arun Krishnan, Gopika Jothydev, Sunitha Telemedicine for diabetes care: An Indian perspective - feasibility and efficacy
author_facet	Kesavadev, Jothydev Saboo, Banshi Shankar, Arun Krishnan, Gopika Jothydev, Sunitha
author_sort	Kesavadev, Jothydev
title	Telemedicine for diabetes care: An Indian perspective - feasibility and efficacy
title_short	Telemedicine for diabetes care: An Indian perspective - feasibility and efficacy
title_full	Telemedicine for diabetes care: An Indian perspective - feasibility and efficacy
title_fullStr	Telemedicine for diabetes care: An Indian perspective - feasibility and efficacy
title_full_unstemmed	Telemedicine for diabetes care: An Indian perspective - feasibility and efficacy
title_sort	telemedicine for diabetes care: an indian perspective - feasibility and efficacy
description	Diabetes is a chronic and costly disease. In India, the usual practice among patients is to visit the doctor once in every 2–3 months to get advice on changes in the dosages of medications. The Diabetes Tele Management System (DTMS®) is a telemedicine based follow-up program originally introduced at Jothydev's Diabetes Research Centre at Trivandrum South India in 1998. It is a chronic disease management system which enables patient to interact lively with a professionally trained multidisciplinary team comprising of diabetes educators, nurses, dieticians, pharmacists, psychologists, physicians, etc., in modifying the dosages of medications, diet, and physical activity either through telephone/email/secure website. The uniquely designed software and the trained multidisciplinary team overcomes the globally recognized major barriers to diabetes management namely fear of hypoglycemia, polypharmacy, discontinuation of stains, and antihypertensives or wrong injection techniques. DTMS is designed to provide individualized therapy advices on glycosylated hemoglobin, blood pressure, and low density lipoprotein customized to multiple patient characteristics which help attain goals of therapy. The system has been tested on various platforms over a decade and was shown to be a patient friendly approach with successful outcomes due to a live “round-the-clock” interactive communication in contrast to text or recorded messages. The major challenge to the widespread use of DTMS® is seeking a source of funding this unique telemedicine program.
publisher	Medknow Publications & Media Pvt Ltd
publishDate	2015
url	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4673803/
_version_	1613511171238789120

Telemedicine for diabetes care: An Indian perspective - feasibility and efficacy

Similar Items